Neurosense Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.72

+0.01 (+1.42%)

As of Jun 30, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +4,793.1% upside

Low Target $27.84

Average Target $35.23

High Target $57.14

Current Price $0.72

Current
$0.72

Target
$35.23

$27.84 $35.23 avg $57.14

Scenario Analysis

Bear Case

$27.84

3,766.7%

Low target

Base Case

$35.23

+4,793.1%

Avg target

Bull Case

$57.14

+7,836.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.28

-68.4% from high

52-Week Low

$0.63

+14.3% from low

Target vs 52W High

$35.23

+1,445.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%